IGC Pharma annual asset turnover
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2025
IGC Pharma Asset Turnover Growth & History (IGC)
IGC Pharma's asset turnover was 0.09 for fiscal 2025.
View full IGC Pharma company overviewIGC Pharma annual asset turnover history
| Fiscal year | Period ended | Asset turnover | Change | Growth |
|---|---|---|---|---|
| 2025 · Dec 31 | 2025-12-31 | 0.09 | — | — |
| 2025 · Mar 31 | 2025-03-31 | 0.14 | 0.04 | +37.22% |
| 2024 | 2024-03-31 | 0.10 | 0.06 | +139.95% |
| 2023 | 2023-03-31 | 0.04 | 0.03 | +349.08% |
| 2022 | 2022-03-31 | 0.01 | −0.02 | −66.71% |
| 2021 | 2021-03-31 | 0.03 | −0.10 | −78.42% |
| 2020 | 2020-03-31 | 0.13 | −0.10 | −43.15% |
| 2019 | 2019-03-31 | 0.23 | 0.03 | +13.96% |
| 2018 | 2018-03-31 | 0.20 | 0.16 | +414.52% |
| 2017 | 2017-03-31 | 0.04 | −0.29 | −88.15% |
| 2016 | 2016-03-31 | 0.32 | −0.08 | −19.48% |
| 2015 | 2015-03-31 | 0.40 | 0.28 | +228.29% |
| 2014 | 2014-03-31 | 0.12 | −0.24 | −65.93% |
| 2013 | 2013-03-31 | 0.36 | 0.17 | +86.53% |
| 2012 | 2012-03-31 | 0.19 | — | — |
IGC Pharma quarterly asset turnover
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Asset turnover | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 · Jun 30 | 2026-06-30 | 0.09 | −0.05 | −36.48% |
| Q1 2026 · Mar 31 | 2026-03-31 | 0.10 | −0.04 | −29.96% |
| Q4 2025 · Dec 31 | 2025-12-31 | 0.09 | −0.03 | −23.90% |
| Q2 2026 · Sep 30 | 2025-09-30 | 0.11 | 0.02 | +24.93% |
| Q1 2026 · Jun 30 | 2025-06-30 | 0.14 | 0.06 | +77.06% |
| Q4 2025 · Mar 31 | 2025-03-31 | 0.14 | 0.04 | +37.22% |
| Q3 2025 | 2024-12-31 | 0.12 | 0.04 | +56.71% |
| Q2 2025 | 2024-09-30 | 0.09 | 0.02 | +26.07% |
| Q1 2025 | 2024-06-30 | 0.08 | 0.02 | +28.45% |
| Q4 2024 | 2024-03-31 | 0.10 | 0.06 | +139.95% |
| Q3 2024 | 2023-12-31 | 0.08 | 0.05 | +162.07% |
| Q2 2024 | 2023-09-30 | 0.07 | 0.05 | +241.77% |
| Q1 2024 | 2023-06-30 | 0.06 | 0.05 | +335.11% |
| Q4 2023 | 2023-03-31 | 0.04 | 0.03 | +349.08% |
| Q3 2023 | 2022-12-31 | 0.03 | 0.02 | +130.50% |
| Q2 2023 | 2022-09-30 | 0.02 | 0.01 | +90.94% |
| Q1 2023 | 2022-06-30 | 0.01 | 0.00 | +16.09% |
| Q4 2022 | 2022-03-31 | 0.01 | −0.02 | −66.71% |
| Q3 2022 | 2021-12-31 | 0.01 | −0.02 | −58.06% |
| Q2 2022 | 2021-09-30 | 0.01 | −0.03 | −75.83% |
| Q1 2022 | 2021-06-30 | 0.01 | −0.08 | −87.19% |
| Q4 2021 | 2021-03-31 | 0.03 | −0.10 | −78.42% |
| Q3 2021 | 2020-12-31 | 0.03 | −0.13 | −81.29% |
| Q2 2021 | 2020-09-30 | 0.04 | −0.21 | −82.62% |
| Q1 2021 | 2020-06-30 | 0.10 | −0.14 | −58.57% |
| Q4 2020 | 2020-03-31 | 0.13 | −0.10 | −43.15% |
| Q3 2020 | 2019-12-31 | 0.16 | −0.03 | −15.88% |
| Q2 2020 | 2019-09-30 | 0.25 | −0.06 | −19.39% |
| Q1 2020 | 2019-06-30 | 0.23 | −0.11 | −31.99% |
| Q4 2019 | 2019-03-31 | 0.23 | 0.03 | +13.96% |
| Q3 2019 | 2018-12-31 | 0.19 | 0.11 | +135.43% |
| Q2 2019 | 2018-09-30 | 0.32 | 0.29 | +991.63% |
| Q1 2019 | 2018-06-30 | 0.35 | 0.32 | +1298.83% |
| Q4 2018 | 2018-03-31 | 0.20 | 0.16 | +414.52% |
| Q3 2018 | 2017-12-31 | 0.08 | −0.06 | −40.91% |
| Q2 2018 | 2017-09-30 | 0.03 | −0.13 | −81.21% |
| Q1 2018 | 2017-06-30 | 0.02 | −0.22 | −89.94% |
| Q4 2017 | 2017-03-31 | 0.04 | −0.29 | −88.15% |
| Q3 2017 | 2016-12-31 | 0.14 | −0.23 | −61.79% |
| Q2 2017 | 2016-09-30 | 0.15 | −0.28 | −64.62% |
| Q1 2017 | 2016-06-30 | 0.25 | −0.17 | −40.99% |
| Q4 2016 | 2016-03-31 | 0.32 | −0.08 | −19.48% |
| Q3 2016 | 2015-12-31 | 0.37 | 0.09 | +33.10% |
| Q2 2016 | 2015-09-30 | 0.44 | 0.29 | +198.59% |
| Q1 2016 | 2015-06-30 | 0.42 | 0.32 | +336.89% |
| Q4 2015 | 2015-03-31 | 0.40 | 0.28 | +228.29% |
| Q3 2015 | 2014-12-31 | 0.27 | 0.09 | +45.19% |
| Q2 2015 | 2014-09-30 | 0.15 | −0.21 | −59.34% |
| Q1 2015 | 2014-06-30 | 0.10 | −0.27 | −73.80% |
| Q4 2014 | 2014-03-31 | 0.12 | −0.24 | −65.93% |
| Q3 2014 | 2013-12-31 | 0.19 | −0.09 | −31.31% |
| Q2 2014 | 2013-09-30 | 0.36 | 0.12 | +49.17% |
| Q1 2014 | 2013-06-30 | 0.36 | 0.16 | +74.46% |
| Q4 2013 | 2013-03-31 | 0.36 | 0.17 | +86.53% |
| Q3 2013 | 2012-12-31 | 0.28 | — | — |
| Q2 2013 | 2012-09-30 | 0.24 | — | — |
| Q1 2013 | 2012-06-30 | 0.21 | — | — |
| Q4 2012 | 2012-03-31 | 0.19 | — | — |
IGC Pharma asset turnover trends
Between the periods ended 2012-03-31 and 2025-12-31, IGC Pharma's asset turnover decreased from 0.19 to 0.09, a change of −0.10. The latest reported quarter, Q2 2026 · Jun 30, shows 0.09.
About the metric
What asset turnover means
Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.
Calculation and source
How asset turnover is calculated
TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review IGC Pharma source filings ↗